9265

YAMASHITA HEALTH CARE HOLDINGS,INC.

ヤマシタヘルスケアホールディングス

Industry
Wholesale Trade
Market
Standard
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Key metrics

Revenue(million JPY)

May 2022
55,146
May 2023
58,195
May 2024
61,555
May 2025
64,486
May 2026
64,149

Operating profit(million JPY)

May 2022
931
May 2023
1,156
May 2024
967
May 2025
838
May 2026
737

Operating profit margin(%)

May 2022
1.69
May 2023
1.99
May 2024
1.57
May 2025
1.3
May 2026
1.15

Profit before tax(million JPY)

May 2022
1,026
May 2023
635
May 2024
871
May 2025
943
May 2026
929

Profit(million JPY)

May 2022
696
May 2023
219
May 2024
580
May 2025
616
May 2026
648

Total assets(million JPY)

May 2022
24,087
May 2023
24,568
May 2024
26,557
May 2025
27,549
May 2026
27,089

Cash and cash equivalents(million JPY)

May 2022
3,976
May 2023
5,825
May 2024
5,300
May 2025
5,698
May 2026
4,127

Cash flows from operating activities(million JPY)

May 2022
581
May 2023
2,166
May 2024
878
May 2025
617
May 2026
88

Cash flows from investing activities(million JPY)

May 2022
-28
May 2023
-107
May 2024
-1,067
May 2025
19
May 2026
-1,322

Cash flows from financing activities(million JPY)

May 2022
-230
May 2023
-209
May 2024
-335
May 2025
-240
May 2026
-337

Return on equity(%)

May 2022
8.9
May 2023
2.8
May 2024
7.1
May 2025
7
May 2026
7.1

Equity ratio(%)

May 2022
33.1
May 2023
32.2
May 2024
32.2
May 2025
32.6
May 2026
34.6

Earnings per share(JPY per share)

May 2022
272.67
May 2023
85.83
May 2024
227.96
May 2025
249.79
May 2026
258.56

Net assets per share(JPY per share)

May 2022
3,126.18
May 2023
3,097.34
May 2024
3,429.08
May 2025
3,640.22
May 2026
3,680.48

Dividend per share(JPY per share)

May 2022
82
May 2023
48
May 2024
70
May 2025
75
May 2026
107

Payout ratio(%)

May 2022
30.07
May 2023
55.92
May 2024
30.71
May 2025
30.03
May 2026
41.38

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.